Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Open Access
- 1 February 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Vascular Health and Risk Management
- Vol. 9, 57-64
- https://doi.org/10.2147/vhrm.s40972
Abstract
Peer reviewed article authored by (Schweizer A, Foley JE, Kothny W, Ahrén B). Read article or submit your manuscript for publishing.Keywords
This publication has 33 references indexed in Scilit:
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2012
- Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitusIndian Journal of Endocrinology and Metabolism, 2012
- Intensifying Treatment of Type 2 Diabetes Mellitus: Adding InsulinPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
- Glucose-Dependent Insulinotropic PolypeptideDiabetes, 2011
- Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trialDiabetes, Obesity and Metabolism, 2011
- Regulation of glucagon secretion by incretinsDiabetes, Obesity and Metabolism, 2011
- Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humansDiabetes, Obesity and Metabolism, 2011
- Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studiesVascular Health and Risk Management, 2011
- Hypoglycemia: Still The Limiting Factor in the Glycemic Management of DiabetesEndocrine Practice, 2008
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.1998